{"contentid": 488436, "importid": NaN, "name": "Europe threatens legal action over AstraZeneca vaccine supplies", "introduction": "The latest chapter in an ongoing saga over European supplies of AstraZeneca\u00e2\u0080\u0099s coronavirus vaccine looks likely to involve legal action.", "content": "<p><span style=\"font-weight: 400;\">The latest chapter in an </span><a href=\"https://www.thepharmaletter.com/article/eu-uk-covid-19-vaccines-spat-turns-to-outright-war\"><span style=\"font-weight: 400;\">ongoing saga</span></a><span style=\"font-weight: 400;\"> over European supplies of AstraZeneca&rsquo;s (LSE: AZN) coronavirus vaccine looks likely to involve legal action.</span></p>\n<p><span style=\"font-weight: 400;\">The European Commission is reportedly asking the 27 EU member states to back litigation against the British firm, which it says is in breach of contractual obligations to supply the product, Vaxzevria.</span></p>\n<p><span style=\"font-weight: 400;\">AstraZeneca has said it inked a so-called &ldquo;best efforts&rdquo; contract with Europe, and that supply chain disruptions prevented it from supplying the estimated amount.</span></p>\n<p><span style=\"font-weight: 400;\">While Europe has received just 30 million doses, the UK has used an exclusive arrangement with the drugmaker, agreed early on in development of the product, to vaccinate a far larger share of its population.</span></p>\n<h2><strong>Long-running dispute</strong></h2>\n<p><span style=\"font-weight: 400;\">With the vaccine rollout in Europe proceeding slowly, officials threatened to block vaccine exports in February, raising concerns over &ldquo;vaccine nationalism.&rdquo;</span></p>\n<p><span style=\"font-weight: 400;\">The EU has said AstraZeneca should divert supplies from its UK supply chain to fulfill what it sees as a legal obligation to provide more.</span></p>\n<p><span style=\"font-weight: 400;\">With tensions rising, the UK and EU agreed in March to discuss &ldquo;what more we can do to ensure a reciprocally beneficial relationship between the UK and EU on COVID-19.&rdquo;</span></p>\n<p><span style=\"font-weight: 400;\">Those discussions appear not to have dissuaded the EU from pursuing a hard line on the matter. The trading bloc is counting on receiving 70 million vaccine doses from AstraZeneca in the second quarter of 2021.</span></p>\n<h2><strong>Vaccine safety monitoring</strong></h2>\n<p><span style=\"font-weight: 400;\">While the EU fights to secure supplies of AstraZeneca&rsquo;s vaccine, which was first approved by the UK regulator in December 2020, several countries have restricted its use to older populations amid concerns over a rare side effect of blood clotting.</span></p>\n<p><span style=\"font-weight: 400;\">Scientists are unclear whether a small number of cerebral venous sinus thrombosis (CVST) cases are linked to the use of the viral vector-based product, partly due to uncertainty over how widespread the rare condition is among the general population.</span></p>\n<p><span style=\"font-weight: 400;\">In an update on Thursday, the UK&rsquo;s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), said it had found 168 major blood clots following a dose of Vaxzevria - equal to 7.9 clots per million doses.</span></p>\n<p><span style=\"font-weight: 400;\">There have been over 20 million doses of the product given in the UK, and public health authorities around the world have confirmed the vaccine to be safe and effective.</span></p>\n<p><span style=\"font-weight: 400;\">In a statement, the MHRA said: \"On the basis of this ongoing review, the advice remains that the benefits of the vaccine outweigh the risks in the majority of people.&rdquo; </span></p>\n<p><span style=\"font-weight: 400;\">The agency has, however, recommended that people under 30 be offered an alternative type of vaccine.</span></p>", "date": "2021-04-23 11:42:00", "meta_title": NaN, "meta_keywords": "vaccine, supplies, legal, Europe, AstraZeneca, action, product, million, doses, European, ongoing, supply, saga, coronavirus, involve, latest, chapter, rar", "meta_description": "The latest chapter in an ongoing saga over European supplies of AstraZeneca\u00e2\u0080\u0099s coronavirus vaccine looks like to involve legal action.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-04-23 11:40:33", "updated": "2021-04-23 12:07:53", "access": NaN, "url": "https://www.thepharmaletter.com/article/europe-threatens-legal-action-over-astrazeneca-vaccine-supplies", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "astrazeneca_big.jpg", "image2id": "astrazeneca_small-1.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, European Medicines Agency, Focus On, Legal, Medicines and Healthcare products Regulatory Agency (MHRA), Production, Public health", "geography_tag": "Europe, UK", "company_tag": "AstraZeneca", "drug_tag": "COVID-19 Vaccine AstraZeneca, Vaxzevria", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-04-23 11:42:00"}